Item 8.01. Other Events.

As disclosed in the Company's press release dated July 17, 2008, on July 17, 2008, PharmaNet Development Group, Inc. (the "Company") entered into a Seventh Amendment (the "Amendment") to its revolving Amended and Restated Credit Agreement, as amended from time to time (the "Credit Agreement") with UBS AG, Stamford Branch and other financial institutions (the "Bank") thereby reinstating the Company's ability to borrow on the Credit Agreement. UBS AG, Stamford Branch, continues to serve as Administrative Agent and Collateral Agent. As a result of this Amendment, certain financial covenants in the Credit Agreement, including certain of the Company's covenants to maintain certain financial ratios, were either waived by the Bank or amended by the parties to reflect the Company's current operations and business needs.

The Amendment does not affect the total committed amount of the credit line, potential interest rates on any borrowings or the remaining term. At this time, the Company has no outstanding balance under the Credit Agreement and any potential future use will be for general company purposes.

The obligations under the Credit Agreement are secured by substantially all of the Company's assets and are due on December 22, 2009.

A copy of the Amendment will be filed as an exhibit to the Company's next appropriate periodic report.

A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01. Financial Statement and Exhibits.

(d) Exhibits

9 9.1

Press Release dated July 17, 2008.

---